NUS Assistant Professor Charged with Drug-Related Offences in Singapore

Regulations by 2FIRSTS.ai
Mar.04.2024
NUS Assistant Professor Charged with Drug-Related Offences in Singapore
NUS assistant professor Jevdic Dorde charged with drug-related offenses, including possession of cannabis-derived e-cigarette device. Case postponed to March 26.

According to a report from Singapore's The Straits Times on February 28th, an assistant professor at the National University of Singapore (NUS), Jevdic Dorde, is being charged with involvement in drug-related offenses involving marijuana.

 

This 39-year-old Serbian man from the School of Computing was charged with one count of drug possession and one count of possessing an e-cigarette device containing derivatives of marijuana.

 

In addition, Dole was also charged with possession of drug paraphernalia on February 27, including four straws and a rubber tube.

 

The National University of Singapore stated in a declaration to The Straits Times on February 28 that since August 2023, Dore has been suspended from work and will undergo its internal disciplinary process while awaiting court trial.

 

A spokesperson from the National University of Singapore added, "All staff at the National University of Singapore are expected to adhere to high standards of professional and personal conduct, including compliance with Singapore laws and regulations."

 

According to court documents, Donald is suspected of using marijuana on or before August 4, 2023. He is charged with possessing an e-cigarette device and drug paraphernalia in a unit in the apartment.

 

The Dorde case has been postponed until March 26th for trial.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Nebraska Lawmakers Consider Major Tax Hikes on Cigarettes, Vapes and Other Nicotine Products
Nebraska Lawmakers Consider Major Tax Hikes on Cigarettes, Vapes and Other Nicotine Products
Nebraska lawmakers are considering two tax bills targeting nicotine products. LB1124 would raise the cigarette tax from $0.64 to $1.64 per pack, while LB1238 would shift cigarettes to a 30% tax on the retailer’s purchase price and increase taxes on alternative nicotine and other tobacco products to 30%. The commentary argues the hikes could raise consumer costs, pressure small retailers, and increase cross-border shopping and illicit market activity.
Feb.04 by 2FIRSTS.ai
NASCAR adds nicotine pouch sponsor Grizzly as official partner; zone renews RCR deal for 2026
NASCAR adds nicotine pouch sponsor Grizzly as official partner; zone renews RCR deal for 2026
NASCAR Holdings has struck a partnership with Grizzly, a nicotine pouch brand under Reynolds American, making it an official sponsor across NASCAR and its track portfolio, with financial terms undisclosed. Separately, zone, a nicotine pouch brand owned by Imperial Brands’ U.S. subsidiary ITG Brands, renewed its relationship with Richard Childress Racing (RCR) and will continue sponsoring Kyle Busch’s No. 8 car during the 2026 season.
Jan.26
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
South Dakota Senate Committee Advances Bill Tightening Nicotine Retail Rules
South Dakota Senate Committee Advances Bill Tightening Nicotine Retail Rules
South Dakota Senate Bill 221 (SB 221), which seeks to regulate the retail sale of nicotine products, has passed the Senate Health and Human Services Committee with a unanimous 7–0 recommendation. The bill was significantly amended, expanding from three to nine pages and shifting its focus from vapor products alone to all nicotine products.
Regulations
Feb.22
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24